Key result
Injection of 1-2 ml of ultrasound contrast medium (Echovist) provided excellent contrast outlining the pericardial space during hemorrhagic pericardiocentesis, with no adverse effects observed.
Why the study?
Does the use of ultrasound contrast medium SH U 454 (Echovist) improve contrast enhancement during pericardiocentesis of hemorrhagic effusions compared to conventional techniques?
Population
Patients undergoing pericardiocentesis for hemorrhagic or loculated effusions
Comparison
Injection of 1-2 ml of ultrasound contrast… vs Conventional technique
Design
Case_series
Authors
Loading...
May aid needle positioning in hemorrhagic pericardiocentesis; hypothesis-generating and should not yet change practice.
Observational
Does the use of ultrasound contrast medium SH U 454 (Echovist) improve contrast enhancement during pericardiocentesis of hemorrhagic effusions compared to conventional techniques?
The use of ultrasound contrast medium SH U 454 (Echovist) provides excellent contrast enhancement to secure correct needle position during pericardiocentesis of hemorrhagic effusions.
Watzinger et al. (1998) conducted an observational in Hemorrhagic or loculated pericardial effusions. Ultrasound contrast medium SH U 454 (Echovist) was evaluated on Contrast quality and adverse effects. Injection of 1-2 ml of ultrasound contrast medium (Echovist) provided excellent contrast outlining the pericardial space during hemorrhagic pericardiocentesis, with no adverse effects observed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: